The treatment, from InSightec, is designed to treat patients who are unable to undergo radiation treatment for their pain. It is a non-invasive, outpatient therapy and was approved for use in uterine fibroids patients in 2004.
More Articles on Pain Management:
5 Tips to Enhance Pain Specialist Communication With Primary Care Physicians
Dr. Jonathan Pedrick Joins OhioHealth
Study Examines Pain After Knee Surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
